Highly Qualified Advisors with Exceptional Track Records
Our board brings an unmatched depth of experience from the medical device and blood diagnostics marketplaces to provide guidance and oversight.
Board of Directors
Noubar Afeyan
CEO, Flagship Pioneering
John McDonough
CEO, Seventh Sense Biosystems
Thomas J. Cahill, MD, PhD
Founder and Managing Partner, Newpath Partners LLC
Marc Ceulemans
Head Strategic Venture Capital & Pharma Equities
Don Hardison
President, CEO and Director of Biotheranostics, Inc.
Peter Hutt, JD
Senior Counsel, Covington & Burling, LLP
Robert Langer, SCD
(Co-founder) Institute Professor, MIT
Harry Wilcox
General Partner, Flagship Pioneering
Easier access and better blood collection experiences change lives
The health information in blood is critical to fully-informed health decisions, but the blood-collection experiences available today fall short of making it as easy and accessible as it can be.
We’re striving to make sure that accessing whole blood samples does not prevent people from living the healthy lives they deserve.
